Search
for
Sort by
Research 91–120 of 318
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- The Rotterdam Study: 2018 update on objectives, design and main results
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
- Insulin Resistance and Skin Diseases
- Polycystic ovary syndrome and impact on health
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L.
- <i>Acorus calamus</i>: a bio-reserve of medicinal values
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Androgens and Antiandrogens
- Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats
- PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ITS CORRELATION WITH METABOLIC SYNDROME
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Cardiovascular risk factors and events in women with androgen excess
- Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study
- Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- Thyroid antibodies in Hashimoto’s thyroiditis patients are positively associated with inflammation and multiple symptoms